Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Neurogene (NGNE) Forecast
NewsEarningsNeurogene (NGNE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Neurogene Stock Price, Quotes and Forecasts | NASDAQ:NGNE | Benzinga
Explore Neurogene stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NGNE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neurogene (NGNE) stock?
You can purchase shares of Neurogene (NASDAQ:NGNE) through any online brokerage.
Who are Neurogene (NGNE) competitors?
Other companies in Neurogene’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Korro Bio (NASDAQ:KRRO), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for Neurogene (NGNE) stock?
Neurogene has a consensus price target of $59.80.
What is the current price for Neurogene (NGNE)?
The stock price for Neurogene (NASDAQ: NGNE) is $14.05 last updated March 26, 2025 at 10:06 AM EDT.
Does Neurogene (NGNE) pay a dividend?
There are no upcoming dividends for Neurogene.
When is Neurogene (NASDAQ:NGNE) reporting earnings?
Neurogene’s Q1 earnings are confirmed for Friday, May 9, 2025.
Is Neurogene (NGNE) going to split?
There is no upcoming split for Neurogene.
What sector and industry does Neurogene (NGNE) operate in?
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.